Activation of stress-responsive promoters by ionizing radiation for deployment in targeted gene therapy

DNA Repair

Volumn 3, Issue 3, 2004, Pages 201-215

  Chastel, Carine ^a,b   Jiricny, Josef ^a,c   Jaussi, Rolf ^a,b  

^a PAUL SCHERRER INSTITUTE   (Switzerland)

^b Biomolecular Research   (Switzerland)

^c Inst of Molecular Cancer Research   (Switzerland)

Author keywords

Cancer; Immediate early genes; Ionizing radiation; P53; Promoter; Radiotherapy; X rays

Indexed keywords

ANTINEOPLASTIC AGENT; EARLY GROWTH RESPONSE FACTOR 1; GANCICLOVIR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MEMBRANE RECEPTOR; PROTEIN C JUN; PROTEIN FOS; PROTEIN P21; PROTEIN P53; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA; TUMOR SUPPRESSOR PROTEIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CLINICAL TRIAL; DRUG MECHANISM; GENE TARGETING; GENE THERAPY; HUMAN; IONIZING RADIATION; MAMMAL CELL; MITOSIS INHIBITION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FAMILY; PROTEIN LOCALIZATION; STRESS; SUICIDE GENE; SYSTEMIC DISEASE; TOXICITY;

MAMMALIA;

EID: 0842346433     PISSN: 15687864     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dnarep.2003.12.002     Document Type: Review

References (109)

1. Schmidt-Ullrich R.K., Dent P., Grant S., Mikkelsen R. B., Valerie K. Signal transduction and cellular radiation responses. Radiat. Res. 153:2000;245-257.
2. Dent P., Yacoub A., Contessa J., Caron R., Amorino G., Valerie K., Hagan M.P., Grant S., Schmidt-Ullrich R. Stress and radiation-induced activation of multiple intracellular signaling pathways. Radiat. Res. 159:2003;283-300.
3. Criswell T., Leskov K., Miyamoto S., Luo G., Boothmanl D.A. Transcription factors activated in mammalian cells after clinically relevant doses of ionizing radiation. Oncogene. 22:2003;5813-5827.
4. Kim S.H., Kim J.H., Djordjevic B. Effects of X-irradiation on RNA and protein synthesis in HeLa cells. Radiat. Res. 42:1970;577-589.
5. Weichselbaum R.R., Hallahan D., Fuks Z., Kufe D. Radiation induction of immediate early genes: effectors of the radiation-stress response. Int. J. Radiat. Oncol. Biol. Phys. 30:1994;229-234.
6. Greenberg M.E., Ziff E.B. Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene. Nature. 311:1984;433-438.
7. Amundson S.A., Fornace A.J. Gene expression profiles for monitoring radiation exposure. Radiat. Prot. Dosim. 97:2001;11-16.
8. Prasad A.V., Mohan N., Chandrasekar B., Meltz M.L. Induction of transcription of "immediate early genes" by low-dose ionizing radiation. Radiat. Res. 143:1995;263-272.
9. Sherman M.L., Datta R., Hallahan D.E., Weichselbaum R.R., Kufe D.W. Ionizing radiation regulates expression of the c-jun protooncogene. Proc. Natl. Acad. Sci. U.S.A. 87:1990;5663-5666.
10. Janknecht R. Regulation of the c-fos promoter. Immunobiology. 193:1995;137-142.
11. Treisman R. Transient accumulation of c-fos RNA following serum stimulation requires a conserved 5′ element and c-fos 3′ sequences. Cell. 42:1985;889-902.
12. Datta R., Rubin E., Sukhatme V., Qureshi S., Hallahan D., Weichselbaum R.R., Kufe D.W. Ionizing radiation activates transcription of the EGR1 gene via CArG elements. Proc. Natl. Acad. Sci. U.S.A. 89:1992;10149-10153.
13. Chai J., Tarnawski A.S. Serum response factor: discovery, biochemistry, biological roles and implications for tissue injury healing. J. Physiol. Pharmacol. 53:2002;147-157.
14. Hazzalin C., Mahadevan L.C. MAPK-regulated transcription: a continuously variable gene switch? Nat. Rev. Mol. Cell Biol. 3:2002;30-40.
15. Sharrocks A.D. Complexities in ETS-domain transcription factor function and regulation: lessons from the TCF (ternary complex factor) subfamily. The Colworth Medal Lecture. Biochem. Soc. Trans. 30:2002;1-9.
16. Choi E.K., Rhee Y.H., Park H.J., Ahn S.D., Shin K.H., Park K.K. Effect of protein kinase C inhibitor (PKCI) on radiation sensitivity and c-fos transcription. Int. J. Radiat. Oncol. Biol. Phys. 49:2001;397-405.
17. Hausser A., Storz P., Hubner S., Braendlin I., Martinez-Moya M., Link G., Johannes F.J. Protein kinase C mu selectively activates the mitogen-activated protein kinase (MAPK) p42 pathway. FEBS Lett. 492:2001;39-44.
18. Amorino G.P., Hamilton V.M., Valerie K., Dent P., Lammering G., Schimdt-Ullrich R.K. EGF-R dependence of radiation-induced transcription factor activation in human breast carcinoma cells. Mol. Cell Biol. 13:2002;2233-2244.
19. Datta R., Hallahan D.E., Kharbanda S.M., Rubin E., Sherman M.L., Huberman E., Weichselbaum R.R., Kufe D.W. Involvement of reactive oxygen intermediates in the induction of c-jun gene transcription by ionizing radiation. Biochemistry. 31:1992;8300-8306.
20. Hallahan D.E., Sukhatme V.P., Sherman M.L., Virudachalam S., Kufe D., Weichselbaum R.R. Protein kinase C mediates X-ray inducibility of nuclear signal transducers EGR1 and JUN. Proc. Natl. Acad. Sci. U.S.A. 88:1991;2156-2160.
21. Kool J., Hamdi M., Cornelissen-Steijger P., van der Eb A.J., Terleth C., van Dam H. Induction of ATF3 by ionizing radiation is mediated via a signaling pathway that includes ATM, Nibrin1, stress-induced MAPkinases and ATF-2. Oncogene. 22:2003;4235-4242.
22. Raingeaud J., Whitmarsh A.J., Barrett T., Derijard B., Davis R.J. MKK3- and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway. Mol. Cell Biol. 16:1996;1247-1255.
23. Hallahan D.E., Dunphy E., Kuchibhotla J., Kraft A., Unlap T., Weichselbaum R.R. Prolonged c-jun expression in irradiated ataxia telangiectasia fibroblasts. Int. J. Radiat. Oncol. Biol. Phys. 36:1996;355-360.
24. Angel P., Karin M. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim. Biophys. Acta. 1072:1991;129-157.
25. Turpaev K.T. Reactive oxygen species and regulation of gene expression. Biochem. (Mosc.). 67:2002;281-292.
26. Brach M.A., Hass R., Sherman M.L., Gunji H., Weichselbaum R., Kufe D. Ionizing radiation induces expression and binding activity of the nuclear factor kappa B. J. Clin. Invest. 88:1991;691-695.
27. Prasad A.V., Mohan N., Chandrasekar B., Meltz M.L. Activation of nuclear factor kappa B in human lymphoblastoid cells by low-dose ionizing radiation. Radiat. Res. 138:1994;367-372.
28. Russell J.S., Tofilon P.J. Radiation-induced activation of nuclear factor-kappaB involves selective degradation of plasma membrane-associated I(kappa) B(alpha). Mol. Biol. Cell. 13:2002;3431-3440.
29. Mohan N., Meltz M.L. Induction of nuclear factor kappa B after low-dose ionizing radiation involves a reactive oxygen intermediate signaling pathway. Radiat. Res. 140:1994;97-104.
30. Lee S.J., Dimtchev A., Lavin M.F., Dritschilo A., Jung M. A novel ionizing radiation-induced signaling pathway that activates the transcription factor NF-κB. Oncogene. 17:1998;1821-1826.
31. Li N., Karin M. Ionizing radiation and short wavelength UV activate NF-kappaB through two distinct mechanisms. Proc. Natl. Acad. Sci. U.S.A. 95:1998;13012-13017.
32. Wang T., Zhang X., Li J.J. The role of NF-kappaB in the regulation of cell stress responses. Int. Immunopharmacol. 2:2002;1509-1520.
33. Honda N., Yagi K., Ding G.R., Miyakoshi J. Radiosensitization by overexpression of the nonphosphorylation form of IkappaB-alpha in human glioma cells. J. Radiat. Res. (Tokyo). 43:2002;283-292.
34. Ding G.R., Honda N., Nakahara T., Tian F., Yoshida M., Hirose H., Miyakoshi J. Radiosensitization by inhibition of IkappaB-alpha phosphorylation in human glioma cells. Radiat. Res. 160:2003;232-237.
35. Russell J.S., Raju U., Gumin G.J., Lang F.F., Wilson D.R., Huet T., Tofilon P.J. Inhibition of radiation-induced nuclear factor-kappaB activation by an anti-Ras single-chain antibody fragment: lack of involvement in radiosensitization. Cancer Res. 62:2002;2318-2326.
36. Schwachtgen J.L., Campbell C.J., Braddock M. Full promoter sequence of human early growth response factor-1 (EGR-1): demonstration of a fifth functional serum response element. DNA Seq. 10:2000;429-432.
37. Datta R., Taneja N., Sukhatme V.P., Qureshi S.A., Weichselbaum R., Kufe D.W. Reactive oxygen intermediates target CC(A/T)6GG sequences to mediate activation of the early growth response 1 transcription factor gene by ionizing radiation. Proc. Natl. Acad. Sci. U.S.A. 90:1993;2419-2422.
38. Lim C.P., Jain N., Cao X. Stress-induced immediated-early gene, egr-1, involves activation of p38/JNK1. Oncogene. 16:1998;2915-2926.
39. Suzuki K., Kodama S., Watanabe M. Extremely low-dose ionizing radiation causes activation of mitogen-activated protein kinase pathway and enhances proliferation of normal human diploid cells. Cancer Res. 61:2001;5396-5401.
40. Meyer R.G., Kupper J.H., Kandolf R., Rodemann H.P. Early growth response-1 gene (Egr-1) promoter induction by ionizing radiation in U87 malignant glioma cells in vitro. Eur. J. Biochem. 269:2002;337-346.
41. Beetz A., Peter R.U., Oppel T., Kaffenberger W., Rupec R.A., Meyer M., van Beuningen D., Kind P., Messer G. NF-kappaB and AP-1 are responsible for inducibility of the IL-6 promoter by ionizing radiation in HeLa cells. Int. J. Radiat. Biol. 76:2000;1443-1453.
42. Martin M., Vozenin M.-C., Gault N., Crechet F., Pfarr C.M., Lefaix J.-L. Coactivation of AP-1 activity and TGF-β1 gene expression in the stress response of normal skin cells to ionizing radiation. Oncogene. 15:1997;981-989.
43. Chen R.H., Su Y.H., Chuang R.L., Chang T.Y. Suppression of TGF-β-induced apoptosis through a PI3/Akt-dependent pathway. Oncogene. 17:1998;1959-1968.
44. Witte L., Fuks Z., Haimovitz-Friedman A., Vlodavsky I., Goodman D.S., Eldor A. Effects of irradiation on the release of growth factors from cultured bovine, porcine, and human endothelial cells. Cancer Res. 49:1989;5066-5072.
45. Lee J.Y., Galoforo S.S., Berns C., Erdos G., Gupta A.K., Ways D.K., Corry P.M. Effect of ionizing radiation on AP-1 binding activity and basic fibroblast growth factor gene expression in drug-sensitive human breast carcinoma MCF-7 and multidrug-resistant MCF-7/ADR cells. J. Biol. Chem. 270:1995;28790-28796.
46. Ader I., Muller C., Bonnet J., Favre G., Cohen-Jonathan E., Salles B., Toulas C. The radioprotective effect of the 24 kDa FGF-2 isoform in HeLa cells is related to an increased expression and activity of the DNA dependent protein kinase (DNA-PK) catalytic subunit. Oncogene. 21:2002;6471-6479.
47. Ader I., Toulas C., Dalenc F., Delmas C., Bonnet J., Cohen-Jonathan E., Favre G. RhoB controls the 24 kDa FGF-2-induced radioresistance in HeLa cells by preventing post-mitotic cell death. Oncogene. 21:2002;5998-6006.
48. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell. 100:2000;57-70.
49. Kastan M.B., Onyekwere O., Sidransky D., Vogelstein B., Craig R.W. Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 51:1991;6304-6311.
50. Kuerbitz S.J., Plunkett B.S., Walsh W.V., Kastan M.B. Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc. Natl. Acad. Sci. U.S.A. 89:1992;7491-7495.
51. Vogelstein B., Lane D., Levine A.J. Surfing the p53 network. Nature. 408:2000;307-310.
52. Levine A.J. p53, the cellular gatekeeper for growth and division. Cell. 88:1997;323-331.
53. Bakkenist C.J., Kastan M.B. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature. 421:2003;499-506.
54. Chen C.Y., Oliner J.D., Zhan Q., Fornace A.J. Jr., Vogelstein B., Kastan M.B. Interactions between p53 and MDM2 in a mammalian cell cycle checkpoint pathway. Proc. Natl. Acad. Sci. U.S.A. 91:1994;2684-2688.
55. Fields S., Jang S.K. Presence of a potent transcription activating sequence in the p53 protein. Science. 249:1990;1046-1049.
56. Pietenpol A., Tokino T., Thiagalingam S., El-Deiry W.S. Sequence-specific transcriptional activation is essential for growth suppression by p53. Proc. Natl. Acad. Sci. U.S.A. 91:1994;1998-2002.
57. Bargonetti J., Manfredi J.J., Chen X., Marshak D.R., Prives C. A proteolytic fragment from the central region of p53 has marked sequence-specific DNA-binding activity when generated from wild-type but not from oncogenic mutant p53 protein. Genes Dev. 7:1993;2565-2574.
58. El-Deiry W.S., Kern S.E., Pietenpol A., Kinzler K.W., Vogelstein B. Definition of a consensus binding site for p53. Nat. Genet. 1:1992;45-49.
59. Wang Y.H., Tsay Y.G., Tan B.C., Lo W.Y., Lee S.C. Identification and characterization of a novel p300-mediated p53 acetylation site, lysine 305. J. Biol. Chem. 278:2003;25568-25576.
60. Zacchi P., Gostissa M., Uchida T., Salvagno C., Avolio F., Volinia S., Ronai Z., Blandino G., Schneider C., Del Sal G. The prolyl isomerase Pin1 reveals a mechanism to control p53 functions after genotoxic insults. Nature. 419:2002;853-857.
61. Nikolaev A.Y., Li M., Puskas N., Qin J., Gu W. Parc: a cytoplasmic anchor for p53. Cell. 112:2003;29-40.
62. Yu J., Zhang L., Hwang P.M., Rago C., Kinzler K.W., Vogelstein B. Identification and classification of p53-regulated genes. Proc. Natl. Acad. Sci. U.S.A. 96:1999;14517-14522.
63. Fei P., El-Deiry W.S. P53 and radiation responses. Oncogene. 22:2003;5774-5783.
64. Gudkov A. Microarray analysis of p53-mediated transcription: multi-thousand piece puzzle or invitation to collective thinking. Cancer Biol. Ther. 2:2003;444-445.
65. Burns T.F., El-Deiry W.S. Microarray analysis of p53 target gene expression patterns in the spleen and thymus in response to ionizing radiation. Cancer Biol. Ther. 2:2003;431-443.
66. El-Deiry W.S., Tokino T., Velculescu V.E., Levy D.B., Parsons R., Trent J.M., Lin D., Mercer W.E., Kinzler K.W., Vogelstein B. WAF1, a potential mediator of p53 tumor suppression. Cell. 75:1993;817-825.
67. Amundson S.A., Bittner M., Chen Y., Trent J., Meltzer P., Fornace A.J. Jr. Fluorescent cDNA microarray hybridization reveals complexity and heterogeneity of cellular genotoxic stress responses. Oncogene. 18:1999;3666-3672.
68. Koutsodontis G., Tentes I., Papakosta P., Moustakas A., Kardassis D. Sp1 plays a critical role in the transcriptional activation of the human cyclin-dependent kinase inhibitor p21(WAF1/Cip1) gene by the p53 tumor suppressor protein. J. Biol. Chem. 276:2001;29116-29125.
69. Russo T., Zambrano N., Esposito F., Ammendola R., Cimino F., Fiscella M., Jackman J., O'Connor P.M., Anderson C.W., Appella E. A p53-independent pathway for activation of WAF1/CIP1 expression following oxidative stress. J. Biol. Chem. 270:1995;29386-29391.
70. Akashi M., Hachiya M., Osawa Y., Spirin K., Suzuki G., Koeffler H.P. Irradiation induces WAF1 expression through a p53-independent pathway in KG-1 cells. J. Biol. Chem. 270:1995;19181-19187.
71. Bunz F., Dutriaux A., Lengauer C., Waldman T., Zhou S., Brown J.P., Sedivy J.M., Kinzler K.W., Vogelstein B. Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science. 282:1998;1497-1501.
72. Hermeking H., Lengauer C., Polyak K., He T.C., Zhang L., Thiagalingam S., Kinzler K.W., Vogelstein B. 14-3-3 sigma is a p53-regulated inhibitor of G2/M progression. Mol. Cell. 1:1997;3-11.
73. Zhan Q., Antinore M.J., Wang X.W., Carrier F., Smith M.L., Harris C.C., Fornace A.J. Jr. Association with Cdc2 and inhibition of Cdc2/Cyclin B1 kinase activity by the p53-regulated protein Gadd45. Oncogene. 18:1999;2892-2900.
74. Amundson S.A., Do K.T., Fornace A.J. Jr. Induction of stress genes by low doses of gamma rays. Radiat. Res. 152:1999;225-231.
75. Kastan M.B., Zhan Q., El-Deiry W.S., Carrier F., Jacks T., Walsh W.V., Plunkett B.S., Vogelstein B., Fornace A.J. Jr. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia- telangiectasia. Cell. 71:1992;587-597.
76. Seoane J., Le H.V., Massague J. Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage. Nature. 419:2002;729-734.
77. Fuchs E.J., McKenna K.A., Bedi A. p53-dependent DNA damage-induced apoptosis requires Fas/APO-1-independent activation of CPP32beta. Cancer Res. 57:1997;2550-2554.
78. Wu G.S., Burns T.F., McDonald E.R. III, Jiang W., Meng R., Krantz I.D., Kao G., Gan D.D., Zhou J.Y., Muschel R., Hamilton S.R., Spinner N.B., Markowitz S., Wu G., El-Deiry W.S. KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene. Nat. Genet. 17:1997;141-143.
79. Takimoto R., El-Deiry W.S. Wild-type p53 transactivates the KILLER/DR5 gene through an intronic sequence-specific DNA-binding site. Oncogene. 19:2000;1735-1743.
80. Polyak K., Xia Y., Zweier J.L., Kinzler K.W., Vogelstein B. A model for p53-induced apoptosis. Nature. 389:1997;300-305.
81. Flatt P.M., Polyak K., Tang L.J., Scatena C.D., Westfall M.D., Rubinstein L.A., Yu J., Kinzler K.W., Vogelstein B., Hill D.E., Pietenpol J.A. p53-dependent expression of PIG3 during proliferation, genotoxic stress, and reversible growth arrest. Cancer Lett. 156:2000;63-72.
82. Zhan Q., Fan S., Bae I., Guillouf C., Liebermann D.A., O'Connor P.M., Fornace A.J. Jr. Induction of bax by genotoxic stress in human cells correlates with normal p53 status and apoptosis. Oncogene. 9:1994;3743-3751.
83. Brady H.J., Salomons G.S., Bobeldijk R.C., Berns A.J. T cells from baxalpha transgenic mice show accelerated apoptosis in response to stimuli but do not show restored DNA damage-induced cell death in the absence of p53 gene product in. EMBO J. 15:1996;1221-1230.
84. McCurrach M.E., Connor T.M., Knudson C.M., Korsmeyer S.J., Lowe S.W. Bax-deficiency promotes drug resistance and oncogenic transformation by attenuating p53-dependent apoptosis. Proc. Natl. Acad. Sci. U.S.A. 94:1997;2345-2349.
85. Oda K., Arakawa H., Tanaka T., Matsuda K., Tanikawa C., Mori T., Nishimori H., Tamai K., Tokino T., Nakamura Y., Taya Y. p53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46- phosphorylated p53. Cell. 102:2000;849-862.
86. Oda E., Ohki R., Murasawa H., Nemoto J., Shibue T., Yamashita T., Tokino T., Taniguchi T., Tanaka N. Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science. 288:2000;1053-1058.
87. Shibue T., Takeda K., Oda E., Tanaka H., Murasawa H., Takaoka A., Morishita Y., Akira S., Taniguchi T., Tanaka N. Integral role of Noxa in p53-mediated apoptotic response. Genes Dev. 17:2003;2233-2238.
88. Nakano K., Vousden K.H. PUMA, a novel proapoptotic gene, is induced by p53. Mol. Cell. 7:2001;683-694.
89. Yu J., Wang Z., Kinzler K.W., Vogelstein B., Zhang L. PUMA mediates the apoptotic response to p53 in colorectal cancer cells. Proc. Natl. Acad. Sci. U.S.A. 100:2003;1931-1936.
90. Weichselbaum R.R., Hallahan D.E., Sukhatme V.P., Kufe D.W. Gene therapy targeted by ionizing radiation. Int. J. Radiat. Oncol. Biol. Phys. 24:1992;565-567.
91. Hallahan D.E., Beckett M.A., Kufe D., Weichselbaum R.R. The interaction between recombinant human tumor necrosis factor and radiation in 13 human tumor cell lines. Int. J. Radiat. Oncol. Biol. Phys. 19:1990;69-74.
92. Hallahan D.E., Mauceri H.J., Seung L.P., Dunphy E.J., Wayne J.D., Hanna N.N., Toledano A., Hellman S., Kufe D.W., Weichselbaum R.R. Spatial and temporal control of gene therapy using ionizing radiation. Nat. Med. 1:1995;786-791.
93. Chung T.D., Mauceri H.J., Hallahan D.E., Yu J.J., Chung S., Grdina W.L., Yajnik S., Kufe D.W., Weichselbaum R.R. Tumor necrosis factor-alpha-based gene therapy enhances radiation cytotoxicity in human prostate cancer. Cancer Gene Ther. 5:1998;344-349.
94. Mauceri H.J., Seetharam S., Beckett M.A., Lee J.Y., Gupta V.K., Gately S., Stack M.S., Brown C.K., Swedberg K., Kufe D.W., Weichselbaum R.R. Tumor production of angiostatin is enhanced after exposure to TNF-alpha. Int. J. Cancer. 97:2002;410-415.
95. Joki T., Nakamura M., Ohno T. Activation of the radiosensitive EGR-1 promoter induces expression of the herpes simplex virus thymidine kinase gene and sensitivity of human glioma cells to ganciclovir. Hum. Gene Ther. 6:1995;1507-1513.
96. Christy B.A., Lau L.F., Nathans D. A gene activated in mouse 3T3 cells by serum growth factors encodes a protein with "zinc finger" sequences. Proc. Natl. Acad. Sci. U.S.A. 85:1988;7857-7861.
97. Marples B., Scott S.D., Hendry J.H., Embleton M.J., Lashford L.S., Margison G.P. Development of synthetic promoters for radiation-mediated gene therapy. Gene Ther. 7:2000;511-517.
98. Scott S.D., Joiner M.C., Marples B. Optimizing radiation-responsive gene promoters for radiogenetic cancer therapy. Gene Ther. 9:2002;1396-1402.
99. Scott S.D., Marples B., Hendry J.H., Lashford L.S., Embleton M.J., Hunter R.D., Howell A., Margison G.P. A radiation-controlled molecular switch for use in gene therapy of cancer. Gene Ther. 7:2000;1121-1125.
100. Greco O., Marples B., Dachs G.U., Williams K.J., Patterson A.V., Scott S.D. Novel chimeric gene promoters responsive to hypoxia and ionizing radiation. Gene Ther. 9:2002;1403-1411.
101. Salloum R.M., Mauceri H.J., Hanna N.N., Gorski D.H., Posner M.C., Weichselbaum R.R. Dual induction of the Epo-Egr-TNF-alpha-plasmid in hypoxic human colon adenocarcinoma produces tumor growth delay. Am. Surg. 69:2003;24-27.
102. Worthington J., Robson T., Murray M., O'Rourke M., Keilty G., Hirst D.G. Modification of vascular tone using iNOS under the control of a radiation-inducible promoter. Gene Ther. 7:2000;1126-1131.
103. Marples B., Greco O., Joiner M.C., Scott S.D. Radiogenetic therapy: strategies to overcome tumor resistance. Curr. Pharm. Des. 9:2003;2105-2112.
104. Soler M.N., Bobe P., Benihoud K., Lemaire G., Roos B.A., Lausson S. Gene therapy of rat medullary thyroid cancer by naked nitric oxide synthase II DNA injection. J. Gene Med. 2:2000;344-352.
105. Worthington J., Robson T., O'Keeffe M., Hirst D.G. Tumour cell radiosensitization using constitutive (CMV) and radiation inducible (WAF1) promoters to drive the iNOS gene: a novel suicide gene therapy. Gene Ther. 9:2002;263-269.
106. Kircheis R., Wagner E. Technology evaluation: TNFerade, GenVec. Curr. Opin. Mol. Ther. 5:2003;437-447.
107. Kufe D., Weichselbaum R. Radiation therapy: activation for gene transcription and the development of genetic radiotherapy-therapeutic strategies in oncology. Cancer Biol. Ther. 2:2003;326-329.
108. Khodarev N.N., Park J.O., Yu J., Gupta N., Nodzenski E., Roizman B., Weichselbaum R.R. Dose-dependent and independent temporal patterns of gene responses to ionizing radiation in normal and tumor cells and tumor xenografts. Proc. Natl. Acad. Sci. U.S.A. 98:2001;12665-12670.
109. Amundson S.A., Bittner M., Fornace A.J. Jr. Functional genomics as a window on radiation stress signaling. Oncogene. 22:2003;5828-5833.